End-Of-Life Care and Advance Directives

Foundations and mechanisms

Core ethical framework in end-of-life care

End-of-life care refers to medical care for patients with serious, life-limiting illness when death is expected or when treatment goals shift from cure/prolongation of life to comfort, dignity, and goal-concordant care. For USMLE Step 1, the key organizing principles are autonomy, beneficence, nonmaleficence, and justice. In competent adults, autonomy generally supersedes physician beneficence: a patient with decision-making capacity may refuse any intervention, including life-sustaining treatment, even if refusal results in death.

Ethically and legally, there is no meaningful distinction between withholding and withdrawing a treatment if the treatment is unwanted or no longer consistent with the patient’s goals. For example, not initiating mechanical ventilation and discontinuing mechanical ventilation are ethically equivalent when based on valid patient preferences. This principle is frequently tested because students often incorrectly assume that stopping an intervention is “killing”; in medical ethics, the underlying disease is considered the cause of death.

Decision-making capacity: required elements

Capacity is a clinical determination made by physicians; competence is a legal determination made by courts. Capacity is decision-specific and can fluctuate, especially in delirium, intoxication, hypoxia, severe depression, or metabolic encephalopathy. A patient may have capacity for a simple decision but not for a complex, high-risk decision.

Element of capacity	Meaning	Common impairment mechanism
Communicate a choice	Patient can consistently state a decision	Aphasia, coma, severe psychosis
Understand	Patient can explain relevant facts: diagnosis, options, risks, benefits	Delirium, dementia, low health literacy without adequate explanation
Appreciate	Patient recognizes how information applies personally	Psychosis, anosognosia, denial so severe it prevents reality-based reasoning
Reason	Patient can compare options logically according to values	Severe cognitive impairment, mania, intoxication

Capacity should not be judged by whether the physician agrees with the patient’s choice. A “bad” or high-risk decision can still be autonomous if the four elements are intact.

Advance directives: classification and function

Advance directives are instruments that preserve autonomy when a patient loses capacity. They apply only when the patient cannot make decisions; a capacitated patient’s current wishes override prior written documents. The two classic forms are the living will and the durable power of attorney for health care.

Instrument	Core function	High-yield point
Living will	Written preferences about future care, commonly regarding CPR, ventilation, artificial nutrition/hydration, dialysis, or comfort care	Guides decisions but may be limited by vague language or unforeseen clinical circumstances
Durable power of attorney for health care	Designates a surrogate decision-maker if the patient lacks capacity	Often more flexible than a living will because a person can interpret values in context
DNR/DNAR order	Medical order not to perform cardiopulmonary resuscitation if pulseless/apneic	Does not mean “do not treat”; antibiotics, fluids, oxygen, vasopressors, or surgery may still be appropriate if goal-concordant
POLST/MOLST	Portable medical order set for seriously ill patients, translating goals into actionable orders	Generally intended for advanced illness/frailty, not healthy young adults

Surrogate decision-making standards

If a patient lacks capacity and no applicable directive is available, decisions are made by an authorized surrogate. The ethical hierarchy is: known patient wishes first, then substituted judgment based on the patient’s values, and finally the best-interest standard if preferences are unknown. Best interest considers relief of suffering, preservation or restoration of function, and proportionality of benefits and burdens.

State laws vary, but typical surrogate priority is spouse or domestic partner, adult children, parents, adult siblings, then other relatives or close friends. On Step 1-style questions, the best answer is usually to identify and follow the appropriate surrogate or advance directive rather than ask the physician, hospital, or ethics committee to decide first. Ethics consultation is useful for conflict, uncertainty, or suspected surrogate misconduct, but it does not replace patient autonomy.

Physiologic and legal definitions of death

Death may be declared by irreversible cessation of circulatory and respiratory function or by brain death. Brain death is irreversible loss of all brain and brainstem function. It is not coma or persistent vegetative state. Prerequisites include known cause of coma, exclusion of confounders such as hypothermia, sedative intoxication, neuromuscular blockade, shock, and severe metabolic derangement. A commonly used temperature threshold is core temperature ≥36°C before brain death examination. The examination demonstrates unresponsiveness, absent brainstem reflexes, and apnea despite adequate carbon dioxide stimulus; apnea testing commonly requires arterial PaCO₂ to rise to ≥60 mm Hg or ≥20 mm Hg above baseline without spontaneous respirations.

Symptom mechanisms and palliative pharmacology

Common terminal symptoms have basic physiologic mechanisms. Dyspnea arises from increased respiratory drive, chemoreceptor stimulation, mechanical load, anxiety, or hypoxemia. Opioids reduce dyspnea partly by decreasing central perception of air hunger and ventilatory drive. Pain at end of life may be nociceptive, neuropathic, inflammatory, or visceral.

Medication	Common starting dose in opioid-naive adults	Mechanism/high-yield adverse effects
Morphine	2.5–5 mg PO every 4 h or 1–2 mg IV every 2–4 h, titrated	μ-opioid receptor agonist; constipation, nausea, sedation, respiratory depression; active metabolites accumulate in renal failure
Hydromorphone	1–2 mg PO every 4–6 h or 0.2–0.4 mg IV every 2–3 h	μ-agonist; useful when morphine intolerance occurs; still requires renal caution
Haloperidol	0.5–1 mg PO/IV/SC every 8–12 h as needed	Dopamine D2 blockade; used for nausea or delirium; risk of QT prolongation and extrapyramidal symptoms
Lorazepam	0.5–1 mg PO/IV/SL every 4–6 h as needed	GABAA positive allosteric modulator; anxiolysis/sedation; may worsen delirium

The principle of double effect permits a treatment intended to relieve suffering even if it foreseeably but unintentionally may hasten death, provided the dose is proportionate to symptom relief. This differs from euthanasia or physician-assisted death, where death is the intended means or outcome. Hospice eligibility in the United States generally requires physician certification of a prognosis of approximately ≤6 months if the disease follows its usual course.

Clinical assessment and investigations

Clinical presentation: when end-of-life ethics questions arise

End-of-life care issues typically present when a patient has a serious, progressive, or irreversible condition and a decision must be made about life-sustaining treatment. Common scenarios include advanced metastatic cancer, end-stage heart failure, severe chronic obstructive pulmonary disease, advanced dementia, devastating stroke, irreversible coma, or critical illness requiring mechanical ventilation, vasopressors, dialysis, artificial nutrition, or cardiopulmonary resuscitation. For USMLE Step 1, the key clinical task is not to choose subspecialty management, but to determine who has decision-making authority, whether the patient has decision-making capacity, and whether valid prior instructions exist.

End-of-life assessment begins with three questions: Is the patient able to decide? If not, is there an advance directive or legally authorized surrogate? Finally, what medical facts define the benefits and burdens of proposed interventions? This integrates clinical prognosis with ethical principles: autonomy, beneficence, nonmaleficence, and justice.

Assessment of decision-making capacity

Capacity is a clinical determination made by the treating physician; competence is a legal determination made by a court. Capacity is decision-specific and can fluctuate, especially with delirium, intoxication, hypoxia, metabolic derangements, or medication effects. A patient may have capacity to choose a low-risk treatment but lack capacity for a complex, high-stakes refusal.

Element of capacity	Meaning	Clinical example
Understanding	Can state the diagnosis, proposed intervention, risks, benefits, and alternatives	“CPR may include chest compressions, defibrillation, intubation, and ICU care.”
Appreciation	Recognizes that information applies personally	“Because my cancer is widespread, CPR is unlikely to restore meaningful recovery.”
Reasoning	Can compare options logically according to values	“I value comfort over a small chance of prolonged survival on a ventilator.”
Communication	Can express a stable choice	Consistently states preference for do-not-resuscitate status.

There is no single laboratory threshold for capacity. However, abnormal physiology should trigger evaluation for reversible impairment: hypoxemia, hypercapnia, sepsis, uremia, hepatic encephalopathy, hypoglycemia, hypercalcemia, intoxication, withdrawal, pain, sleep deprivation, and medications such as benzodiazepines, opioids, anticholinergics, corticosteroids, and sedative-hypnotics.

Differential diagnosis for impaired decision-making near the end of life

Condition	Key features	High-yield distinction
Delirium	Acute onset, fluctuating attention, altered consciousness	Often reversible; use Confusion Assessment Method: acute/fluctuating course plus inattention, and either disorganized thinking or altered level of consciousness.
Dementia	Chronic progressive cognitive decline	Capacity may remain for simple decisions; diagnosis alone does not eliminate autonomy.
Major depression	Hopelessness, anhedonia, guilt, suicidal ideation	May impair appreciation or reasoning; distinguish refusal based on stable values from treatable suicidality.
Psychosis	Delusions, hallucinations, disorganized thought	Lack of capacity only if psychotic beliefs affect the specific decision.
Intoxication/withdrawal	Variable mental status, autonomic findings, toxidrome	Capacity should be reassessed when clinically sober or stabilized.

Investigations: documents, surrogates, and clinical facts

The most important “investigations” in end-of-life ethics are verification of patient preferences and legal authority. Under the Patient Self-Determination Act of 1990, health care institutions receiving Medicare or Medicaid funds must ask adult patients about advance directives and document them, but cannot require them as a condition of care.

• Advance directive: A written statement of preferences for future care if the patient loses capacity. Forms vary by state.
• Living will: Specifies desired or refused interventions in defined circumstances, such as terminal illness or persistent unconsciousness.
• Durable power of attorney for health care: Designates a surrogate decision-maker. This is usually more flexible than a living will because it applies to unforeseen clinical situations.
• POLST/MOLST: Portable medical orders for seriously ill patients; unlike a general advance directive, it is an actionable clinician-signed order set regarding CPR, intubation, artificial nutrition, and transfer.
• DNR order: Applies specifically to withholding CPR during cardiopulmonary arrest; it does not mean “do not treat,” and does not automatically preclude antibiotics, fluids, analgesia, oxygen, or hospitalization.

If the patient lacks capacity and no directive exists, identify the legally authorized surrogate according to state hierarchy, commonly: court-appointed guardian, spouse, adult children, parents, adult siblings, then other relatives or close friends. The surrogate should use substituted judgment—what the patient would have wanted. If preferences are unknown, the surrogate uses the best-interest standard, weighing benefits and burdens.

Interpretation and thresholds relevant to prognosis and death

Hospice eligibility in the United States generally requires physician certification that life expectancy is ≤6 months if the disease follows its usual course. This is a prognostic threshold, not a requirement to stop all treatment; hospice emphasizes comfort-focused care. Palliative care is broader and may be provided at any stage of serious illness alongside disease-directed therapy.

When considering withdrawal or withholding of life support, the ethical distinction is not between “doing” and “not doing”; both are ethically permissible when consistent with patient preferences. The clinically relevant distinction is whether an intervention provides benefit proportional to its burdens.

Death may be determined by irreversible cessation of circulatory and respiratory function or by irreversible cessation of all functions of the entire brain, including the brainstem. Brain death assessment requires exclusion of confounders such as hypothermia, intoxication, severe metabolic derangement, or neuromuscular blockade. Common adult prerequisites include core temperature at least 36°C and adequate blood pressure, often systolic blood pressure ≥100 mm Hg or mean arterial pressure ≥75 mm Hg. Apnea testing is positive when no respiratory effort occurs despite arterial carbon dioxide rising to PaCO₂ ≥60 mm Hg and at least 20 mm Hg above baseline, with adequate oxygenation and hemodynamic stability.

Classic legal cases inform Step 1 ethics: Cruzan v Director, Missouri Department of Health affirmed that competent patients have a constitutional right to refuse unwanted treatment and that states may require clear evidence of wishes for incapacitated patients. The practical exam principle is straightforward: a capacitated patient’s informed refusal should generally be honored, even if refusal may result in death.

Management, pharmacology and procedures

Initial approach: stabilize, assess capacity, and clarify goals

End-of-life management begins with standard acute care only to the extent consistent with the patient’s goals. A patient with decision-making capacity may accept or refuse any intervention, including life-sustaining treatment. Capacity is task-specific and requires the ability to understand relevant information, appreciate consequences, reason about options, and communicate a stable choice. If capacity is absent, clinicians follow a valid advance directive or the legally authorized surrogate using substituted judgment; if preferences are unknown, use the best-interest standard.

• Withholding vs withdrawing treatment: ethically and legally equivalent. For example, not starting mechanical ventilation and discontinuing mechanical ventilation are both permissible when consistent with patient wishes.
• Do-not-resuscitate (DNR) order: applies specifically to cardiopulmonary resuscitation during cardiac or respiratory arrest; it does not mean “do not treat.” Antibiotics, fluids, oxygen, analgesia, and other treatments may still be provided if goal-concordant.
• Physician Orders for Life-Sustaining Treatment (POLST/MOLST): portable medical orders used mainly for seriously ill patients; more actionable than a living will in emergencies.

Common end-of-life symptom management

The main clinical goal is relief of suffering while respecting autonomy. The ethical principle of double effect permits medications that may foreseeably but unintentionally shorten life if the intent is symptom relief, the treatment is proportionate, and no less harmful alternative exists. This is distinct from euthanasia or physician-assisted death, in which death is the intended means or outcome.

Symptom	Common treatment	High-yield pharmacology
Pain or dyspnea	Morphine 2.5–5 mg PO every 4 hours or 1–2 mg IV every 2–4 hours initially; titrate to effect	μ-opioid receptor agonist; decreases pain transmission and reduces air hunger. Oral:IV morphine conversion is approximately 3:1. Major adverse effects: constipation, nausea, sedation, respiratory depression.
Opioid-induced constipation	Senna 8.6–17.2 mg PO daily to twice daily ± polyethylene glycol 17 g PO daily	Tolerance develops to sedation and nausea, but not reliably to constipation; prescribe bowel regimen with scheduled opioids.
Anxiety, terminal agitation	Lorazepam 0.5–1 mg PO/SL/IV every 4–6 hours as needed	Benzodiazepine; potentiates GABAA. Useful for anxiety; may worsen delirium in some patients.
Delirium, hallucinations, severe agitation	Haloperidol 0.5–2 mg PO/IV/SC every 4–8 hours as needed	D2 receptor antagonist; monitor for extrapyramidal symptoms and QT prolongation.
Respiratory secretions	Glycopyrrolate 0.1–0.2 mg SC/IV every 2–4 hours or scopolamine patch 1.5 mg every 72 hours	Antimuscarinic drugs reduce secretions; glycopyrrolate poorly crosses the blood-brain barrier, causing less CNS toxicity.
Nausea/vomiting	Ondansetron 4–8 mg PO/IV every 8 hours or metoclopramide 5–10 mg PO/IV every 6 hours	Ondansetron blocks 5-HT3; metoclopramide blocks D2 and increases GI motility.

Procedures and treatment limitation

Procedural management includes decisions about CPR, intubation, mechanical ventilation, vasopressors, dialysis, artificial nutrition/hydration, and implanted devices. A competent patient may refuse these even if refusal leads to death. Surrogates may not demand medically nonbeneficial interventions; clinicians should communicate prognosis, recommend goal-concordant options, and use ethics consultation when conflict persists.

• Terminal extubation: withdrawal of mechanical ventilation when continued support is inconsistent with goals. Pre-medicate for dyspnea or anxiety, commonly with an opioid and/or benzodiazepine; the intent is comfort, not hastening death.
• Artificial nutrition/hydration: considered medical treatment, not basic care; may be declined. At the end of life, tube feeding often does not prevent aspiration and may cause discomfort, diarrhea, fluid overload, or need for restraints.
• Implantable cardioverter-defibrillator deactivation: ethically permissible to prevent painful shocks during dying; pacemaker deactivation requires careful discussion because effects vary depending on pacemaker dependence.
• CPR outcomes: in-hospital survival to discharge after CPR is often approximately 15%–25% overall and lower in advanced metastatic cancer, severe frailty, or multisystem organ failure; this helps frame informed consent.

Hospice, palliative care, and follow-up

Palliative care is interdisciplinary symptom-focused care appropriate at any disease stage and can be provided alongside curative therapy. Hospice is generally for patients with an expected prognosis of ≤6 months if the disease follows its usual course and the patient elects comfort-focused care. Follow-up includes reassessing symptoms, medication adverse effects, caregiver burden, spiritual distress, and whether documented orders still reflect current preferences.

Important complications include undertreated pain, opioid toxicity, delirium, aspiration, pressure ulcers, and family conflict. Opioid overdose classically causes miosis, respiratory depression, and coma; naloxone can reverse life-threatening toxicity but may precipitate severe pain or withdrawal, so in palliative patients it is used cautiously and titrated when reversal is truly desired. Documentation should include capacity assessment, participants in the discussion, patient values, chosen code status, specific treatment limits, and surrogate contact information.

Exam controversies and advanced synthesis

Core guideline principles tested on Step 1

End-of-life ethics is usually tested as an application of autonomy, beneficence, nonmaleficence, and justice. The central exam rule is: a patient with decision-making capacity may refuse any intervention, even if refusal predictably results in death. This includes mechanical ventilation, vasopressors, dialysis, antibiotics, artificial nutrition/hydration, and blood products. Withholding a treatment and withdrawing an already-started treatment are ethically and legally equivalent; the underlying disease, not the physician, is considered the cause of death.

Issue	High-yield ethical rule	Common exam trap
DNR order	Refuses CPR only: chest compressions, defibrillation, and intubation during cardiac arrest unless otherwise specified.	Do not assume DNR means “do not treat.” Treat pain, dyspnea, infection, dehydration, and reversible distress if consistent with goals.
Advance directive	Applies when the patient lacks capacity; includes living will and durable power of attorney for health care.	A capacitous patient’s current verbal decision overrides a prior written directive.
Surrogate decision-making	Use substituted judgment first; best-interest standard if preferences are unknown.	Family preference does not override known patient wishes.
Artificial nutrition/hydration	Considered medical treatment; may be refused or withdrawn.	Not ethically mandatory solely because it is “basic care.” Comfort feeding may still be appropriate.

Capacity, surrogates, and advance directives: viva-level integration

Decision-making capacity is clinical and task-specific, not a global legal status. The patient must demonstrate 4 abilities: understand relevant information, appreciate consequences for self, reason among options, and communicate a stable choice. Capacity can fluctuate with delirium, hypoxia, hypercalcemia, intoxication, uncontrolled pain, or sedatives. A Mini-Mental State Examination score is not determinative; a patient with cognitive impairment may still have capacity for a simple decision.

If capacity is absent, follow the applicable hierarchy: appointed durable power of attorney for health care, court-appointed guardian, spouse/domestic partner, adult children, parents, adult siblings, then other close relatives or friends depending on jurisdiction. Step 1 generally expects the physician to identify the legally authorized surrogate, clarify the patient’s values, and avoid asking, “What do you want?” Instead ask, “What would the patient choose if able to speak?”

POLST/MOLST, DNR, and emergency care

POLST/MOLST forms are portable medical orders, typically intended for patients with serious illness or frailty whose clinicians would not be surprised if they died within approximately 1 year. Unlike a living will, a POLST is immediately actionable across care settings and may specify CPR status, hospitalization preference, antibiotics, and artificial nutrition. In an emergency, if no valid DNR/POLST is available and the patient lacks capacity, the default is to provide stabilizing treatment under presumed consent while searching for documentation or a surrogate.

Brain death, coma, and persistent vegetative state

The Uniform Determination of Death Act defines death as irreversible cessation of circulatory and respiratory functions or irreversible cessation of all functions of the entire brain, including the brainstem. Brain death requires an established irreversible cause, exclusion of confounders such as hypothermia, shock, intoxication, or severe metabolic derangement, absent brainstem reflexes, and apnea testing. During apnea testing, the classic threshold is arterial PaCO₂ ≥60 mm Hg or a rise of ≥20 mm Hg above baseline without respiratory effort. Brain death is legally death; consent is not required to discontinue organ-supporting technology after appropriate determination, although sensitive communication is essential.

Do not confuse brain death with coma or vegetative state. In a persistent vegetative state, sleep-wake cycles and autonomic function may persist, but awareness is absent. The patient is alive and decisions about life-sustaining treatment depend on advance directives or surrogate judgment.

Palliative sedation, opioids, and the doctrine of double effect

Palliative care aims to relieve suffering and may be provided alongside curative treatment. Hospice in the United States usually requires a physician-estimated prognosis of ≤6 months if the disease follows its usual course. Opioids for terminal dyspnea or pain are ethically permissible even if respiratory rate decreases, provided the intent is symptom relief and doses are proportionate. This is the doctrine of double effect: an action with a good intended effect and a foreseeable but unintended harmful effect may be permissible.

Medication	Typical palliative starting example	High-yield cautions
Morphine	2.5–5 mg PO every 4 h in opioid-naïve frail patients; IV doses are lower because oral:IV potency is roughly 3:1.	Active metabolites accumulate in renal failure; monitor sedation, constipation, nausea.
Hydromorphone	0.2–0.5 mg IV every 2–3 h as needed in opioid-naïve patients.	Useful alternative when morphine metabolites are problematic, though caution remains in renal disease.
Midazolam	Used for refractory terminal agitation or palliative sedation; half-life approximately 1.5–3 h.	Palliative sedation is not euthanasia when intent is relief of refractory symptoms, not death.

Controversies: physician-assisted dying, euthanasia, and futility

Physician-assisted dying generally means a physician provides a lethal prescription that the patient self-administers; legality varies by jurisdiction and is not the Step 1 default. Euthanasia means the clinician directly administers a lethal intervention; it is illegal in most US jurisdictions and should not be chosen as an exam answer. By contrast, honoring refusal of ventilation or stopping vasopressors at a patient’s request is neither assisted suicide nor euthanasia.

Medical futility arises when an intervention cannot achieve its physiologic goal or offers no meaningful benefit relative to the patient’s goals. If a family demands nonbeneficial CPR for a dying patient, the physician should communicate prognosis, explore values, involve ethics consultation, and follow institutional policy. Do not provide treatments solely because requested if they are medically inappropriate, but do not abandon the patient: continue comfort care, explanation, and support.

Evidence and systems-level lessons

The landmark SUPPORT trial enrolled approximately 9,105 seriously ill hospitalized adults and tested an intervention to improve prognostic communication and end-of-life decision-making. It did not significantly improve timing of DNR orders, ICU use, or pain outcomes, highlighting that advance directives alone do not guarantee goal-concordant care. Step 1 synthesis: documents matter, but the physician’s ethical task is an iterative process—assess capacity, identify the correct decision-maker, clarify values, translate values into orders, and relieve suffering.